VNRX

VolitionRx
VNRX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$65.50M
EV
$69.01M
Shares Outstanding
109.49M
Beta
1.06

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$2.94
P/E 2025E
-
P/Revenue 2025E
17.35x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About VolitionRx Limited

gainify
VNRX

VolitionRx Limited

VNRX

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test ...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Reynolds, Cameron

Employees

82

IPO Date

2012-03-02

Headquarters

1489 West Warm Springs Road, Suite 110, Henderson, Nevada, 89014, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.